REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study today in Nature ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic ...

WASHINGTON (Reuters) - Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit. Shares in ...

A new study from deCODE genetics uses pedigrees and sequence data from 64,806 Icelanders to shed light on the rate and nature of mutations in mitochondrial DNA (mtDNA) and the peculiar dynamics of its ...

Hakon Jonsson and Gudny A. Arnadottir, scientists at deCODE genetics and authors on the paper, 'Sequence diversity lost in early pregnancy, in Nature. In a study published in Nature today “Sequence ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic ...

LONDON, Jan 21 (Reuters) - Iceland's Decode Genetics ehf returned as a private biotech company with new finance on Thursday after being acquired from its former parent by a consortium of investors.

A new study from deCODE genetics and collaborators is the first to uncover a strong recessive component in Alzheimer's disease. In 2013, deCODE genetics and collaborators were first to associate a ...

The scientists at deCODE Genetics, a subsidiary of Amgen, sought to deepen the understanding of cis-acting influences of sequence variants on CpG methylation. In the study, the scientists were able to ...

Sequencing the genome is one thing, but applying the data produced from that process to clinical care is a whole other thing. A new startup called NextCODE Health has launched with $15 million and a ...

TRENTON, N.J. (AP) — Biotech pioneer Amgen Inc., in a bid for a big edge in using people’s genetic information to find better ways to attack diseases, is buying human genetics research and analytics ...